Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blier

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|October 29, 2011
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatryThomas C Baghai, Pierre Blier, David S Baldwin, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 16, 2011
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disordersThomas C Baghai, Pierre Blier, David S Baldwin, et al.
The Journal of Clinical Psychiatry|August 29, 2002
Selecting methodologies for the evaluation of differences in time to response between antidepressantsStuart A Montgomery, Per Bech, Pierre Blier, et al.
Journal of Psychiatric Research|February 4, 2014
Combination antidepressant therapy for major depressive disorder: speed and probability of remissionJonathan W Stewart, Patrick J McGrath, Claude Blondeau, et al.
CNS Spectrums|April 14, 2025
Urgency to Treat and Early Optimized Treatment in Major Depressive Disorder: Consequences of Delayed Treatment, Barriers to Implementation, and Practical Strategies for CliniciansOloruntoba J Oluboka, Jeffrey Habert, Atul Khullar, et al.
International Clinical Psychopharmacology|October 6, 2007
Which antidepressants have demonstrated superior efficacy? A review of the evidenceStuart A Montgomery, David S Baldwin, Pierre Blier, et al.
The Lancet. Psychiatry|December 20, 2020
Reconceptualising treatment-resistant depression as difficult-to-treat depressionR Hamish McAllister-Williams, Celso Arango, Pierre Blier, et al.
JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
BMC Psychiatry|August 2, 2014
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersMartin A Katzman, Pierre Bleau, Pierre Blier, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
European Archives of Psychiatry and Clinical Neuroscience|October 29, 2011
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatryThomas C Baghai, Pierre Blier, David S Baldwin, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 16, 2011
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disordersThomas C Baghai, Pierre Blier, David S Baldwin, et al.
The Journal of Clinical Psychiatry|August 29, 2002
Selecting methodologies for the evaluation of differences in time to response between antidepressantsStuart A Montgomery, Per Bech, Pierre Blier, et al.
Journal of Psychiatric Research|February 4, 2014
Combination antidepressant therapy for major depressive disorder: speed and probability of remissionJonathan W Stewart, Patrick J McGrath, Claude Blondeau, et al.
CNS Spectrums|April 14, 2025
Urgency to Treat and Early Optimized Treatment in Major Depressive Disorder: Consequences of Delayed Treatment, Barriers to Implementation, and Practical Strategies for CliniciansOloruntoba J Oluboka, Jeffrey Habert, Atul Khullar, et al.
International Clinical Psychopharmacology|October 6, 2007
Which antidepressants have demonstrated superior efficacy? A review of the evidenceStuart A Montgomery, David S Baldwin, Pierre Blier, et al.
The Lancet. Psychiatry|December 20, 2020
Reconceptualising treatment-resistant depression as difficult-to-treat depressionR Hamish McAllister-Williams, Celso Arango, Pierre Blier, et al.
JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
BMC Psychiatry|August 2, 2014
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersMartin A Katzman, Pierre Bleau, Pierre Blier, et al.
Pageof 23